We herein report the case of a 23-year-old man who presented with recurrent pancreatitis and was diagnosed with primary pancreatic extranodal natural killer/T-cell lymphoma, nasal type, involving the right ventricle. The cardiac involvement was screened and confirmed by transthoracic echocardiography (TTE), cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. Although the patient did not have any cardiac symptoms or evidence of arrhythmia before chemotherapy, he presented with fatal newly developed ventricular tachycardia during the early stages of chemotherapy. The follow-up TTE after his chemotherapy demonstrated markedly decreased thickness of the invaded myocardium, thus suggesting that the myocardium infiltrated by lymphoma cells might become vulnerable to fatal arrhythmia with tumor regression.Key words: extranodal NK-T cell lymphoma, nasal type, heart neoplasms, ventricular tachycardia
Case ReportA 23-year-old man was admitted due to intermittent abdominal pain of 2 months duration. He was treated for recurrent pancreatitis and did not have any other previous medical history or alcohol history. The chest X-ray demonstrated mild cardiomegaly. Electrocardiography (ECG) showed ST-segment elevation in the V1, V2 and V3 leads (Fig. 1). The QT interval on the ECG was within the normal range. Telemetry did not reveal any arrhythmia, such as a premature ventricular complex (PVC) or ventricular tachycardia (VT), and the cardiac enzyme was normal.On an abdominal CT, the pancreas was enlarged with peripancreatic infiltration, and the distal tail portion of the pancreas was not observed. An endoscopic ultrasound guided needle biopsy of the pancreas showed diffuse interstitial infiltration of atypical lymphoid cells with extensive necrosis. Immunophenotypically, the infiltrate was composed predominantly of T-cells, which were cytoplasmic CD3 (cyCD3) positive. Although the cells were CD56 negative, there was nuclear atypia and diffuse positive staining in the